Back to Journals » Hypoxia » Volume 4 » default


Archive: Volume 4, 2016

Combination effects of sorafenib with PI3K inhibitors under hypoxia in colorectal cancer

Bhatia DR, Thiagarajan P

Hypoxia 2016, 4:163-174

Published Date: 8 December 2016

The Three "Musketairs" – Lasker Prize 2016 goes to the protagonists of hypoxia research

Wenger RH, Katschinski DM

Hypoxia 2016, 4:161-162

Published Date: 25 November 2016

Control of the heart rate of rat embryos during the organogenic period

Ritchie HE, Ragnerstam C, Gustafsson E, Jonsson JM, Webster WS

Hypoxia 2016, 4:147-159

Published Date: 8 November 2016

Phosphorylation of the PDH complex precedes HIF-1-mediated effects and PDK1 upregulation during the first hours of hypoxic treatment in HCC cells

Zimmer AD, Walbrecq G, Kozar I, Behrmann I, Haan C

Hypoxia 2016, 4:135-145

Published Date: 16 August 2016

Erythropoietin and a nonerythropoietic peptide analog promote aortic endothelial cell repair under hypoxic conditions: role of nitric oxide

Heikal L, Ghezzi P, Mengozzi M, Stelmaszczuk B, Feelisch M, Ferns GAA

Hypoxia 2016, 4:121-133

Published Date: 16 August 2016

Preconditioning with ethyl 3,4-dihydroxy benzoate augments aerobic respiration in rat skeletal muscle

Nimker C, Singh DP, Saraswat D, Bansal A

Hypoxia 2016, 4:109-120

Published Date: 13 May 2016

Oxygen-dependent regulation of aquaporin-3 expression

Hoogewijs D, Vogler M, Zwenger E, Krull S, Zieseniss A

Hypoxia 2016, 4:91-97

Published Date: 21 April 2016

Sevoflurane mitigates shedding of hyaluronan from the coronary endothelium, also during ischemia/reperfusion: an ex vivo animal study

Chen C, Chappell D, Annecke T, Conzen P, Jacob M, Welsch U, Zwissler B, Becker BF

Hypoxia 2016, 4:81-90

Published Date: 15 April 2016

PHD2: from hypoxia regulation to disease progression

Meneses AM, Wielockx B

Hypoxia 2016, 4:53-67

Published Date: 11 April 2016

Ascorbate availability affects tumor implantation-take rate and increases tumor rejection in Gulo–/– mice

Campbell EJ, Vissers MCM, Dachs GU

Hypoxia 2016, 4:41-52

Published Date: 8 April 2016

Erythropoietin and the use of a transgenic model of erythropoietin-deficient mice

Pichon A, Jeton F, El Hasnaoui-Saadani R, Hagström L, Launay T, Beaudry M, Marchant D, Quidu P, Macarlupu JL, Favret F, Richalet JP, Voituron N

Hypoxia 2016, 4:29-39

Published Date: 7 April 2016

The 2-oxoglutarate analog 3-oxoglutarate decreases normoxic hypoxia-inducible factor-1α in cancer cells, induces cell death, and reduces tumor xenograft growth

Koivunen P, Fell SM, Lu W, Rabinowitz JD, Kung AL, Schlisio S

Hypoxia 2016, 4:15-27

Published Date: 4 March 2016

Fifteen days of 3,200 m simulated hypoxia marginally regulates markers for protein synthesis and degradation in human skeletal muscle

D’Hulst G, Ferri A, Naslain D, Bertrand L, Horman S, Francaux M, Bishop DJ, Deldicque L

Hypoxia 2016, 4:1-14

Published Date: 3 March 2016